Specify a stock or a cryptocurrency in the search bar to get a summary
Biotage AB
0GRPBiotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden. Address: Vimpelgatan 5, Uppsala, Sweden, 751 03
Analytics
WallStreet Target Price
2 171.15 SEKP/E ratio
59.2064Dividend Yield
0.84 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 0GRP
Dividend Analytics 0GRP
Dividend growth over 5 years
14 %Continuous growth
2 yearsPayout Ratio 5 years average
51 %Dividend History 0GRP
Stock Valuation 0GRP
Financials 0GRP
Results | 2019 | Dynamics |